Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.33 |
| ▸ | PDE9A | O76083 | 1/20 | 0.31 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.31 |
| ▸ | TK1 | P04183 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | HBB | P68871 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13952086 | 0.97 | TYMP (0.35) | TYMPMEN1KMT2ATSHRPDE3A | |
| SCHEMBL12674166 | 0.90 | TYMP (0.36) | TYMPMEN1KMT2ATSHRPDE3A | |
| SCHEMBL13951963 | 0.86 | TYMP (0.36) | TYMPMEN1KMT2ATSHRPDE3A | |
| SCHEMBL13952070 | 0.86 | TYMP (0.32) | TYMPMDM2 | |
| SCHEMBL13952066 | 0.85 | ABL1 (0.32) | MDM2 | |
| SCHEMBL13952168 | 0.82 | HINT1 (0.33) | TYMPMEN1KMT2ATSHRPDE9A | |
| SCHEMBL13930520 | 0.82 | TYMP (0.49) | TYMPMEN1KMT2A | |
| SCHEMBL13375800 | 0.81 | TYMP (0.40) | TYMPMEN1KMT2AMDM2 | |
| SCHEMBL13952176 | 0.81 | HDAC6 (0.31) | TYMPMDM2 | |
| SCHEMBL13951955 | 0.80 | MEN1 (0.43) | MEN1KMT2ATSHRPDE3ATK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090053710-A1 | FUNCTIONAL MOLECULE, FUNCTIONAL MOLECULE SYNTHESIZING AMIDITE AND TARGET SUBSTANCE ANALYSIS METHOD | FUJITSU LIMITED (JP) | 2009-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090053710-A1 | FUNCTIONAL MOLECULE, FUNCTIONAL MOLECULE SYNTHESIZING AMIDITE AND TARGET SUBSTANCE ANALYSIS METHOD | TACR1, TACR2, ATIC | TYMP 2415/4885MEN1 2580/4885KMT2A 2968/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.